Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Firmonertinib (mesylate) | 2130958-55-1 | 100.0% | 664.70 | 500 MG
Supplier: Medchemexpress LLC HY112870A500MG
Firmonertinib mesylate (Alflutinib; Furmonertinib) is an orally active, mutant-selective, and blood-brain barrier penetrant EGFR inhibitor. It inhibits EGFR active mutations as well as the T790M acquired resistant mutation, with potential for research into cancer diseases, especially advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins mutation.
- Orally active
- Mutant-selective
- Blood-brain barrier penetrant EGFR inhibitor
- Inhibits EGFR active mutations and the T790M acquired resistant mutation
- Potential for research of cancer diseases, particularly advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins mutation
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?